THU 02 JUL 2026 · GMT EDITION A WHITESTONE INTELLIGENCE PUBLICATION
MARKETS · CYBER · MEMOS · MODELS
DAILY ISSUES26 MAY27 MAY28 MAY29 MAY30 MAY31 MAY01 JUN02 JUN03 JUN04 JUN05 JUN06 JUN07 JUN08 JUN09 JUN10 JUN11 JUN12 JUN13 JUN14 JUN15 JUN16 JUN17 JUN18 JUN19 JUN21 JUN22 JUN23 JUN24 JUN25 JUN26 JUN27 JUN28 JUN29 JUN30 JUN01 JUN02 JUNALL ›
FRONT PAGE / MEMOS / MEM-2026-06-22-F1
MEMOS · sec filings · 2026-06-22SCOOP 63

FTC Finalizes Consent Order Requiring Rollins to Stop Enforcing Noncompetes Against More Than 18,000 Employees

The Federal Trade Commission finalized a consent order requiring Rollins Inc.

·FILED ISSUE 2026-06-22·1 MIN READ·RE-VERIFIED 2026-07-02 UTC·✓ RE-VERIFIED 2026-07-02

At a glance

  • The FTC finalized a consent order against Rollins Inc. in a noncompete matter, per the agency's June 22, 2026 release.
  • The order requires Rollins to stop enforcing noncompete agreements against more than 18,000 employees nationwide, per the FTC.

VERDICT — CONFIRMED

pipeline-backfill confidence · primary + corroborating sources verified · re-verified 2026-07-02 UTC
Memos desk illustration
Generated desk illustration · The Dossier Wire · not a photograph

The Federal Trade Commission finalized a consent order requiring Rollins Inc. to stop enforcing noncompete agreements against more than 18,000 employees nationwide, per the FTC's June 22 press release.

Rollins is described by the agency as one of the largest pest-control companies in the United States. The finalized order converts what had been a proposed settlement in the noncompete matter into a binding obligation on the company.

What is confirmed is the finalization of the order and its scope — more than 18,000 employees nationwide, per the FTC. The conduct alleged in the underlying complaint, the terms of the noncompetes at issue, and any compliance-reporting requirements attached to the order were not carried in the feed and remain unverified here.

Key facts on file

  • The FTC finalized a consent order against Rollins Inc. in a noncompete matter, per the agency's June 22, 2026 release.
  • The order requires Rollins to stop enforcing noncompete agreements against more than 18,000 employees nationwide, per the FTC.

OFFICIAL RECORD

FTC — Press Releases
— (2026-06-22) · fetched at filing · archived at publication

Sources · two-source rule

PRIMARY · DOCFTC — Press Releases— (2026-06-22)
Share
Filed by the Memos desk · verified by the verification desk · re-verified 2026-07-02 · Our standards: the two-source rule ›
CITE THIS FILE — The Dossier Wire · mem-2026-06-22-f1 · filed 2026-06-22 · https://thedwire.com/wire/mem-2026-06-22-f1-ftc-finalizes-consent-order-requiring-rollins-to-stop.html · Primary and corroborating sources listed above; archived at publication. Republishing & licensing: hello@thedwire.com.
More from Memos FULL DESK ›
Memos desk illustration
Generated desk illustration · not a photograph
MEMOS · SCOOP 55

U.S. Launches Trade Investigation Into German Plan to Cut Pharmaceutical Spending

The United States has launched a trade investigation into a German plan to cut spending on pharmaceuticals, a move that could result in fresh tariffs, per The Wall Street Journal's June 19 report. Per the Journal, the investigation follows Berlin's announcement that it would require drugmakers to offer bigger discounts on medicines.

✓ verifiednewSOURCE ↗
READ THE FILE ›
Memos desk illustration
Generated desk illustration · not a photograph
MEMOS · SCOOP 67

SEC, CFTC Seek Public Comment to Further Clarify and Harmonize Derivatives Product Definitions

The Securities and Exchange Commission and the Commodity Futures Trading Commission issued a joint request for public comment on potential opportunities to further update, clarify and harmonize certain derivatives product definitions, per the SEC's June 18 announcement. The CFTC published companion releases the same day. The request forms

✓ verifiednewSOURCE ↗
READ THE FILE ›
FTC Requires Aurobindo to Divest Four Generic Drug Products to Complete $250 mil
Photo: G. Edward Johnson · via Wikimedia Commons · CC BY 4.0
MEMOS · SCOOP 60

FTC Requires Aurobindo to Divest Four Generic Drug Products to Complete $250 million Lannett Acquisition

The Federal Trade Commission moved to require Aurobindo Pharma Limited to divest four generic drug products in order to complete its $250 million acquisition of Lannett Company Inc., per the FTC's June 18 press release. Per the agency, the proposed consent order is intended to resolve anticompetitive concerns and protect American patients

✓ verifiednewSOURCE ↗
READ THE FILE ›

The morning wire in your inbox — every brief, primary sources linked, no noise.

Free tier. The Wire — continuous desk briefs · Records archive · Bureau alerts.

Stored to the wire's subscriber list. No spam, unsubscribe any time.